Study to Evaluate the Efficacy, Safety and Tolerability of IMU-838 in Patients With Relapsing Multiple Sclerosis
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Robert J. Fox, MD
Mellen Center for MS, Neurological Institute, Cleveland Clinic, Ohio
Principal InvestigatorKOL profile →
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
76 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Erebouni Medical Center
Yerevan, Armenia
- Heratsi Hospital Complex 1
Yerevan, Armenia
- Saint Gregory the Illuminator Medical Center
Yerevan, Armenia
- Ucc of Rep of Srpska
Banja Luka, Bosnia and Herzegovina
- Cantonal Hospital Bihac Dr. Irfan Ljubijankic
Bihać, Bosnia and Herzegovina
- University Clinical Center Sarajevo
Sarajevo, Bosnia and Herzegovina
- University Clinical Center of Sarajevo
Sarajevo, Bosnia and Herzegovina
- University Clinical Center Tuzla
Tuzla, Bosnia and Herzegovina
- Astra Clinic
Tallinn, Estonia
- University Hospital Muenster, Institute Translational Neurology Dept. Neurology
Münster, Germany
- Post-Graduation Institute of Medical Education and Research (pgimer)
Chandigarh, India
- Fortis Memorial Research Institute
Gurugramam, India
- Polakulath Narayanan Renai Medicity Mssh
Kochi, India
- Dr Ram Manohar Lohia Institute of Medical Sciences
Lucknow, India
- All India Institute of Medical Sciences
New Delhi, India
- Gb Pant Institute of Postgraduate Medical Education and Research
New Delhi, India
- Sri Guru Ram Das Institute of Medical Sciences and Research
Punjābi Bāgh, India
- Dks Pgi
Raipur, India
- Hospital Nacional Dos de Mayo
Lima, Peru
- Nzoz Novo-Med
Katowice, Poland
- Nzoz Wielospecjalistyczna Poradnia Lekarska "synapsis"
Katowice, Poland
- Neuro-Medic Janusz Zbrojkiewicz
Katowice, Poland
- Indywidualna Praktyka Lekarska Prof. Konrad Rejdak
Lublin, Poland
- Nzoz Neuromed
Lublin, Poland
- Instytut Zdrowia Boczarska
Oświęcim, Poland
- Nzoz Hertmanowskiej
Plewiska, Poland
- Nzoz Neuro-Kard
Poznan, Poland
- Centrum Medyczne Neuroprotect
Warsaw, Poland
- Futuremeds Warszawa Centrum
Warsaw, Poland
- Centrum Med. Ibismed
Zabrze, Poland
- Clubul Sanatatii Srl
Campulung Muscel, Romania
- Spitalul Clinic Cf Constanta
Constanța, Romania
- Aria Clinic Srl
Sibiu, Romania
- Klinicko Bolnicki Centar Dr Dragisa Misovic - Dedinje
Belgrade, Serbia
- Klinicko Bolnicki Centar Zvezdara
Belgrade, Serbia
- Vojnomedicinska Akademija
Belgrade, Serbia
- Univerzitetski Klinicki Centar Kragujevac
Kragujevac, Serbia
- General Hospital Leskovac
Leskovac, Serbia
- Univerzitetski Klinicki Centar Nis
Niš, Serbia
- Hsptl Sveti Vracevi
Novi Kneževac, Serbia
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 12 Jan 2022
- Primary completion
- 30 Nov 2026
- Completion
- 31 Oct 2033
- Last update posted
- 23 Feb 2026
- Registered enrollment
- 1,100
- Registry id
- NCT05201638
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.